Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Sentinel network for monitoring in vitro susceptibility of Plasmodium falciparum to antimalarial drugs in Colombia: a proof of concept.

Aponte SL, Díaz G, Pava Z, Echeverry DF, Ibarguen D, Rios M, Murcia LM, Quelal C, Murillo C, Gil P, Björkman A, Osorio L.

Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:123-9.

3.

In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Côte d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine.

Brice BK, William Y, Lacina O, Félix Y, Hugues A, Léonardo B, André M, Joseph D.

Tanzan J Health Res. 2010 Jan;12(1):73-9.

PMID:
20737832
4.

[In vitro susceptibility of Colombian Plasmodium falciparum isolates to different antimalarial drugs].

Arango E, Carmona-Fonseca J, Blair S.

Biomedica. 2008 Jun;28(2):213-23. Spanish.

5.
6.

A histidine-rich protein 2-based malaria drug sensitivity assay for field use.

Noedl H, Attlmayr B, Wernsdorfer WH, Kollaritsch H, Miller RS.

Am J Trop Med Hyg. 2004 Dec;71(6):711-4.

PMID:
15642959
7.

Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay.

Tyner SD, Lon C, Se Y, Bethell D, Socheat D, Noedl H, Sea D, Satimai W, Schaecher K, Rutvisuttinunt W, Fukuda MM, Chaorattanakawee S, Yingyuen K, Sundrakes S, Chaichana P, Saingam P, Buathong N, Sriwichai S, Chann S, Timmermans A, Saunders DL, Walsh DS.

Malar J. 2012 Jun 13;11:198. doi: 10.1186/1475-2875-11-198.

8.

Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.

Menard D, Djalle D, Manirakiza A, Yapou F, Siadoua V, Sana S, Matsika-Claquin MD, Nestor M, Talarmin A.

Am J Trop Med Hyg. 2005 Aug;73(2):239-43.

PMID:
16103582
9.

Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.

Espinal CA, Cortes GT, Guerra P, Arias AE.

Am J Trop Med Hyg. 1985 Jul;34(4):675-80.

PMID:
3895999
10.

Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006.

Parola P, Pradines B, Simon F, Carlotti MP, Minodier P, Ranjeva MP, Badiaga S, Bertaux L, Delmont J, Morillon M, Silai R, Brouqui P, Parzy D.

Am J Trop Med Hyg. 2007 Sep;77(3):431-7.

PMID:
17827355
11.
12.

Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.

Chaorattanakawee S, Tyner SD, Lon C, Yingyuen K, Ruttvisutinunt W, Sundrakes S, Sai-gnam P, Johnson JD, Walsh DS, Saunders DL, Lanteri CA.

Malar J. 2013 Jul 12;12:239. doi: 10.1186/1475-2875-12-239.

13.

Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.

Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K.

Acta Trop. 2010 Feb;113(2):190-4. doi: 10.1016/j.actatropica.2009.10.016. Epub 2009 Oct 30.

PMID:
19879850
14.

A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials--increased sensitivity of P. falciparum to chloroquine in Senegal.

Ndiaye D, Patel V, Demas A, LeRoux M, Ndir O, Mboup S, Clardy J, Lakshmanan V, Daily JP, Wirth DF.

Am J Trop Med Hyg. 2010 Feb;82(2):228-30. doi: 10.4269/ajtmh.2010.09-0470.

15.

Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.

Rason MA, Randriantsoa T, Andrianantenaina H, Ratsimbasoa A, Menard D.

Trans R Soc Trop Med Hyg. 2008 Apr;102(4):346-51. doi: 10.1016/j.trstmh.2008.01.021. Epub 2008 Mar 5.

PMID:
18321546
16.

[National Network study to perpetuate the surveillance of Plasmodium falciparum sensitivity to antimalarials in Madagascar].

Randrianarivelojosia M, Rakotonjanabelo LA, Mauclère P, Ratsimbasoa A, Raharimalala LA, Ariey F.

Arch Inst Pasteur Madagascar. 2002;68(1-2):73-8. French.

PMID:
12643098
17.

Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives.

Noedl H, Wernsdorfer WH, Kollaritsch H, Looareesuwan S, Miller RS, Wongsrichanalai C.

Wien Klin Wochenschr. 2003;115 Suppl 3:23-7.

PMID:
15508776
18.

Variation of incubation time in an in vitro drug susceptibility test of Plasmodium falciparum isolates studied in the Solomon Islands.

Inaba H, Ohmae H, Kano S, Faarado L, Boaz L, Leafasia J, Suzuki M.

Parasitol Int. 2001 Mar;50(1):9-13.

PMID:
11267927
19.

In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.

Lim P, Chim P, Sem R, Nemh S, Poravuth Y, Lim C, Seila S, Tsuyuoka R, Denis MB, Socheat D, Fandeur T.

Acta Trop. 2005 Jan;93(1):31-40.

PMID:
15589795
20.

Malaria drug-sensitivity testing: new assays, new perspectives.

Noedl H, Wongsrichanalai C, Wernsdorfer WH.

Trends Parasitol. 2003 Apr;19(4):175-81. Review.

PMID:
12689648

Supplemental Content

Support Center